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Abstract
Background: Epidemiological studies suggest that physical activity reduces the risk of colon
cancer in humans. Results from animal studies, however, are inconclusive. The present study
investigated the effects of voluntary exercise on intestinal tumor formation in two different animal
models, ApcMin/+ mice and azoxymethane (AOM)/dextran sulfate sodium (DSS)-treated mice.
Methods: In Experiments 1 and 2, five-week old female ApcMin/+ mice were either housed in regular
cages or cages equipped with a running wheel for 6 weeks (for mice maintained on the AIN93G
diet; Experiment 1) or 9 weeks (for mice on a high-fat diet; Experiment 2). In Experiment 3, male
CF-1 mice at 6 weeks of age were given a dose of AOM (10 mg/kg body weight, i.p.) and, 12 days
later, 1.5% DSS in drinking fluid for 1 week. The mice were then maintained on a high-fat diet and
housed in regular cages or cages equipped with a running wheel for 16 weeks.
Results: In the ApcMin/+ mice maintained on either the AIN93G or the high-fat diet, voluntary
exercise decreased the number of small intestinal tumors. In the AOM/DSS-treated mice
maintained on a high-fat diet, voluntary exercise also decreased the number of colon tumors. In
ApcMin/+ mice, voluntary exercise decreased the ratio of serum insulin like growth factor (IGF)-1 to
IGF binding protein (BP)-3 levels. It also decreased prostaglandin E2 and nuclear -catenin levels,
but increased E-cadherin levels in the tumors.
Conclusion: These results indicate hat voluntary exercise inhibited intestinal tumorigenesis in
ApcMin/+ mice and AOM/DSS-treated mice, and the inhibitory effect is associated with decreased
IGF-1/IGFBP-3 ratio, aberrant -catenin signaling, and arachidonic acid metabolism.
Background
Colorectal cancer is the second most common form of
cancer in incidence and mortality in developed countries
[1]. While its etiology remains unknown, it is thought that
both genetic and environmental factors play critical roles
in causing colorectal cancer. Epidemiological studies con-
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sistently show that physical activity is associated with a
reduced risk of colon cancer [2-5]. However, the protec-
tive effect of exercise against colon carcinogenesis has not
been consistently demonstrated in animal models [6-9].
The inconsistent results observed in animal studies is
likely due to the nature of the animal model as well as the
type of exercise employed. For example, voluntary exercise
was shown to inhibit 1,2-dimethylhydrazine- or
azoxymethane-induced colon tumorigenesis in rats [6,7],
whereas forced exercise was shown not to inhibit intesti-
nal tumorigenesis in ApcMin/+ mice [8]. Mehl et al., how-
ever, noted that intestinal tumor formation in ApcMin/+
mice was inhibited by forced exercise but not by voluntary
exercise [9]. Colbert et al. reported that voluntary exercise
combined with food deprivation and weight loss resulted
in a reduction in tumor formation in male ApcMin/+mice
[10]. Therefore, additional studies are required to evaluate
the potential protective effects of physical exercise against
intestinal tumor formation.
ApcMin/+ mice carry a dominant heterozygous nonsense
mutation at codon 850 of the mouse homologue of the
human tumor suppressor gene, APC (Adenomatous polypo-
sis coli). This mutation is significantly implicated in both
sporadic and inherited human colorectal carcinogenesis
[12-14].  ApcMin/+  mice, therefore, are recognized as a
genetically relevant animal model mimicking human
intestinal carcinogenesis and have been utilized exten-
sively for various chemoprevention studies [15].
Azoxymethane (AOM)-induced and dextran sulfate
sodium (DSS)-promoted colon tumorigenesis in mice is
an inflammation-associated colon carcinogenesis model
that has been used in chemoprevention studies [11]. The
present study was designed to investigate whether volun-
tary exercise inhibits intestinal tumorigenesis in two dif-
ferent animal models, ApcMin/+  mice and AOM/DSS-
treated mice. To further elucidate the mechanisms of the
inhibition of tumorigenesis, the effects of exercise on
insulin-like growth factor (IGF)-1 and IGF binding pro-
tein (IGFBP)-3 ratio, aberrant -catenin signaling, and
arachidonic acid metabolism were also investigated in the
ApcMin/+ mice.
Methods
Breeding and Genotyping of ApcMin/+ Mice
Male ApcMin/+ (C57BL/6J) and female wild-type littermate
mice were initially purchased from The Jackson Labora-
tory (Bar Harbor, ME) as founders, and our own breeding
colony was established in the animal facility of the Susan
Lehman Cullman Laboratory for Cancer Research (Rut-
gers, The State University of New Jersey, Piscataway, NJ).
Pups produced from the colony were weaned at 3 weeks
of age. Genotyping was performed by routine PCR assays
on tail DNA following the procedure previously described
[16]. Five-week old female ApcMin/+ mice were transferred
to the animal facility of the Department of Psychology
(Rutgers, The State University of New Jersey, Piscataway,
NJ) for the exercise studies.
Animal Treatment and Tissue Harvesting
All animal experiments were performed under protocols
no. 02-027 and 87-060 approved by the Institutional Ani-
mal Care and Use Committee at Rutgers University. In
Experiment 1, 5-week old female ApcMin/+ mice on the
AIN-93G diet (containing 7% fat as soy been oil, Research
Diets, Inc.) were housed in regular cages or cages
equipped with a running wheel for 6 weeks until the
experiment was terminated at 11 weeks of age. In Experi-
ment 2, 5-week old female ApcMin/+ mice were placed on a
high-fat diet (using AIN76A diet as the base by Dyets, Inc.,
Bethlehem, PA) containing 20% fat [17] and housed in
regular cages or cages equipped with a running wheel for
9 weeks until the experiment was terminated at 14 weeks
of age. The running wheel used was 7.0 cm in width and
16.5 cm in diameter for an inner circumference of 51.8
cm. Five mice were group-housed in each cage equipped
with free access to the running wheel. Revolutions per day
were measured by a digital counter (Fisher Scientific, Pitts-
burgh, PA) attached outside the running wheel. The total
number of revolutions per day was converted to total kil-
ometers per day. Mice were routinely checked for any
abnormalities. All mice were euthanized by CO2 asphyxi-
ation. Blood was taken by cardiac puncture (Experiment
2), allowed to clot for 2 h at room temperature, and then
centrifuged for 30 min at 3,000 × g. The supernatant was
retained as serum sample and frozen at -80°C. The small
intestine and colon were removed, washed with ice-cold
PBS, opened longitudinally, and flattened on filter paper.
The number, location, and size of visible tumors in the
entire intestine were determined under an illuminated
magnifier (2×). Alternatively, the flattened tissues on filter
paper were placed on dry ice briefly in order to score the
visible tumors as described previously [16]. Visible
tumors were then excised using microdissection scissors
(Fine Science Tools. Inc., Foster City, CA) and frozen at -
80°C.
In Experiment 3, male CF-1 mice at 6 weeks of age
(Charles River Laboratories, Wilmington, MA) were given
a dose of AOM (10 mg/kg body weight, i.p.) or the vehicle
(sterile saline). Twelve days later, they were given 1.5%
DSS (molecular weight of 36,000–50,000, ICN Biochem-
icals Inc., Costa Mesa, CA) in drinking fluid for 1 week.
The mice were then placed on a high-fat diet (using
AIN93M diet as the base by Research Diets, Inc., New
Brunswick, NJ) containing 20% fat (mixture of 27% corn
oil, 16% beef tallow, 10% lard, 12% butter fat, 30%
hydrogenated soybean oil, and 5% peanut oil) [17] and
housed in regular cages or cages equipped with a running
wheel for 16 weeks. Five mice were group-housed in eachBMC Cancer 2008, 8:316 http://www.biomedcentral.com/1471-2407/8/316
Page 3 of 8
(page number not for citation purposes)
cage equipped with free access to the running wheel. Body
weights, food and fluid consumption, and general health
status were monitored weekly. At the end of experiment,
mice were sacrificed by CO2 asphyxiation. At necropsy,
colons were removed, washed with ice-cold saline,
opened longitudinally, flattened on filter paper, and fixed
in 10% buffered formalin for 24 h. Visible colon tumors
were scored in the fixed tissues. The length, width, and
height of each tumor were measured using calipers (VWR
International, INC., Bridgeport, NJ).
Western Blot Analyses
Nuclear and postnuclear fractions (fraction without
nuclear fraction) were prepared from frozen tumors using
NE-PER Nuclear and Cytoplasmic Extraction Reagent Kit
(Pierce Biotechnology, Lockford, IL) [16]. Protease and
phosphatase inhibitor cocktails (Sigma) as well as N-
acetyl-Leu-Leu-norleucinal (a proteosome inhibitor; Cal-
biochem, San Diego, CA) were added to extraction buffers
from the kit. The protein concentration was determined
using a bicinchoninic acid protein assay kit (Pierce Bio-
technology). Tumor extracts (denatured at 95°C for 5 min
in Laemmli sample buffer) containing equal amounts of
protein were subjected to SDS-PAGE (4–15% gradient,
Bio-Rad, Hercules, CA). Gels were transferred onto poly-
vinylidene difluoride membranes (Bio-Rad), and then the
membranes were incubated with blocking buffer (Li-Cor
Biosciences, Lincoln, NE) for 1 h at room temperature.
Membranes were probed with primary antibody in block-
ing buffer at 4°C overnight. After washing with TBS con-
taining 0.1% Tween-20 three times, the membranes were
incubated with secondary antibodies conjugated to IR
fluorophore, Alexa Fluor 680 (Molecular Probes, Eugene,
OR) or IRDye 800 (Rockland Immnunochemicals, Gil-
bertsville, PA). Fluorescence was detected with the Odys-
sey Infrared Imaging System (Li-Cor Biosciences). -
Catenin and E-cadherin antibodies were purchased from
BD Bioscience (San Jose, CA). -Actin and histone H3
antibodies were purchased from Sigma and Cell Signaling
Technology, Inc. (Beverly, MA), respectively.
Enzyme Immunoassay
Serum IGF-1 and IGFBP-3 levels were determined using
Quantikine Mouse IGF-1 Immunoassay kit (R&D System,
Inc., Minneapolis, MN) and DuoSet Mouse IGFBP-3
Enzyme Immunoassay Development Kit (R&D System,
Inc.) following the manufacturer's protocol. Molar ratio
of IGF-1 to IGFBP-3 was calculated by 3.7 × IGF-1 (ng/
ml)/IGFBP-3 (ng/ml) due to 1 ng/mL IGF-I = 0.130 nM
IGF-I and 1 ng/mL IGFBP3 = 0.036 nM IGFBP-3.
Procedures for the Prostaglandin E2  (PGE2) enzyme
immunoassay (EIA) were previously described [16]. In
brief, the frozen tumors were placed into ice-cold T-PER
tissue protein extraction buffer (Pierce Biotechnology)
containing protease inhibitor cocktails (Sigma) and
indomethacin (a cyclooxygenase inhibitor, Cayman
Chemical, Ann Arbor, MI), and homogenized with 50
strokes in an ice-cold Dounce homogenizer (Wheaton,
Millville, NJ). After centrifugation for 10 min at 12,000 ×
g, the supernatants were retained as a whole-tissue extract.
Tissue extracts were acidified with HCl to pH 2.5, vortexed
for 1 min after adding 800 L of ethyl acetate, and then
centrifuged at 3,000 × g for 10 min (Sorvall RT 6000B).
The organic layer was collected and then dried under
speed vacuum evaporator (VWR International, INC.). The
dried samples were stored at -80°C until analysis. Each
sample was reconstituted in EIA buffer (Cayman Chemi-
cal). Levels of PGE2 were measured using an EIA kit (Cay-
man Chemical).
Statistical Analyses
For simple comparisons between two groups, two-tailed
Student's t-tests were used. Since our prediction was that
exercise would reduce tumor formation, the one-tailed
Student's t-test was used as a back-up only if the two-tailed
t-test showed borderline significance. Two-way analysis of
variance (ANOVA) was used for combining data from
more than one experiment (with two factors, treatment
and experiment). Several normality tests (Anderson-Dar-
ling, Cramer-von Mises, Kolmogorov-Smirnov, and Sha-
piro-Wilk tests) were used for determining if a
transformation of the response variable (tumor number)
was needed.
Results
Effects of voluntary exercise on intestinal tumorigenesis 
and body fat levels in ApcMin/+ mice on AIN93G or high-fat 
diets (Experiments 1 and 2)
In Experiment 1, female ApcMin/+ mice maintained on the
AIN93G diet in cages equipped with a running wheel for
6 weeks starting at 5 weeks of age ran approximately 2.8
km/mouse/day, with an assumption that only one mouse
was on the running wheel at a time. As shown in Table 1,
control female ApcMin/+ mice that were housed in regular
cages on the AIN93G diet had 29.2 ± 4.4 tumors in the
small intestine and 0.6 ± 0.2 tumors in the colon. ApcMin/
+ mice that were housed in cages equipped with running
wheels for 6 weeks had 31% fewer tumors in the small
intestine than control ApcMin/+ mice (p < 0.05). Only 0.4–
0.6 colon tumors per mouse (<3% of the total intestinal
tumors) were found. Neither the colon tumor multiplicity
(Table 1) nor incidence (data not shown) was signifi-
cantly affected by the voluntary exercise. The 6-week vol-
untary exercise resulted in a 51% decrease in omental fat
pad weight/body weight (6.89 ± 1.02 mg/g versus 13.96 ±
1.57 mg/g in the control ApcMin/+ mice; p < 0.05) and a
26% decrease in retroperitoneal fat weight/body weight
(2.64 ± 0.37 mg/g versus 3.59 ± 0.43 mg/g in the control
ApcMin/+ mice). The voluntary exercise slightly increasedBMC Cancer 2008, 8:316 http://www.biomedcentral.com/1471-2407/8/316
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food and fluid intake (~10%) without a significant influ-
ence on final body weights (18.9 g average). None of the
groups exhibited noticeable signs of toxicity during the
experimental period.
In Experiment 2, female ApcMin/+ mice maintained on a
high-fat diet in cages equipped with a running wheel for 9
weeks ran approximately 3.5 km/mouse/day. The 9-weeks
of voluntary exercise resulted in a 29% decrease in tumor
numbers in the small intestine (p = 0.05; Table 1), a value
similar to the inhibition (31%) found in ApcMin/+ mice on
the AIN93G diet (Experiment 1 in Table 1). The voluntary
exercise resulted in a more prominent decrease in the
number of large size tumors (52% decrease in >2 mm
tumors; p < 0.005) than the number of small size tumors
(15% decrease in <1 mm tumors) in the small intestine.
The 9-weeks of voluntary exercise resulted in a 34%
decrease in omental fat pad weight/body weight (11.1 ±
5.9 mg/g versus 16.9 ± 1.8 mg/g in the control ApcMin/+
mice; p < 0.02) and a 40% decrease in retroperitoneal fat
weight/body weight (4.0 ± 0.6 mg/g versus 6.7 ± 0.8 mg/
g in the control ApcMin/+ mice; p < 0.01) without a signifi-
cant influence on final body weights (20.8 ± 0.3 mg/g ver-
sus 21.3 ± 0.4 g in the control ApcMin/+ mice). The exercise
slightly increased food and fluid intake (~10%).
Effect of voluntary exercise on serum IGF-1 and IGFBP-3 
levels
In the female ApcMin/+ mice maintained on the high-fat
diet (Experiment 2), the 9-week long voluntary exercise
increased serum IGFBP-3 levels by 19% (p < 0.03) and
slightly decreased serum IGF-1 levels (by 9%), resulting in
a 26% decrease in the molar ratio of IGF-1 to IGFBP3 lev-
els (Table 3; p < 0.005).
Effect of voluntary exercise on E-cadherin and nuclear -
catenin levels in small intestinal tumors
By Western blot analyses, we measured levels of E-cad-
herin and nuclear -catenin in small intestinal tumors of
ApcMin/+ mice maintained on the AIN93G diet (Experi-
ment 1). As shown in Figures 1A and 1B, voluntary exer-
cise resulted in a 2.6-fold increase in E-cadherin levels and
Table 1: Effect of voluntary exercise on intestinal tumor formation in ApcMin/+ mice maintained on AIN93G diet or a high-fata
Group (N) Small intestinal tumors Colon tumors
Region Size Total
Proximal Middle Distal 1 mm 1–2 mm  2 mm
Experiment 1 on AIN93G diet (5 – 11 wk of age)
Control (27) 7.9 ± 1.4 - 21.3 ± 3.3 - - - 29.2 ± 4.4 0.6 ± 0.2
Exercise (28) 4.5 ± 0.9c - 15.7 ± 3.0 - - - 20.2 ± 3.8b 0.4 ± 0.1
Experiment 2 on High-fat diet (5 – 14 wk of age)
Control (19) 4.0 ± 0.4 12.1 ± 1.7 14.7 ± 2.0 18.0 ± 2.4 8.1 ± 1.3 4.8 ± 0.6 30.8 ± 3.4 0.6 ± 0.2
Exercise (19) 2.7 ± 0.3c 7.3 ± 1.6c 12.0 ± 1.4 15.3 ± 1.9 4.4 ± 0.9c 2.3 ± 0.4 d 22.0 ± 2.8c 0.4 ± 0.1
a Results of Experiments 1 and 2. In Experiment 1, the small intestine was divided into two segments (proximal and distal), and the tumor size was 
not scored because the majority of tumors in 11-week-old mice were ~1 mm in diameter. The number of mice was accumulated from 4 identical 
experiments that were done with smaller numbers of mice per group. Data were then combined and analyzed through a statistical adjustment; the 
effects of two factors, treatment (exercise) and experiment, as well as the interaction of treatment and experiment, on the response variable, total small 
intestinal tumor numbers (square-rooted to stabilize the variance), were initially assessed by two-way ANOVA; factors found not to affect the 
response variable significantly were excluded in the final statistical analyses. bA statistically significant treatment (exercise) effect was found (p < 
0.05). In Experiment 2, the small intestine was divided into three segments (proximal, middle and distal), and the tumor size was scored Each value 
represents mean ± SE of number of mice (N). c: p  0.05 by two-tailed t-test;d: p < 0.005 by two-tailed t-test.
Table 2: Effect of voluntary exercise on serum IGF-1 and IGFBP-3 levels in ApcMin/+ mice on high-fat dieta
Groups (N) IGF-1 levels
(ng/ml)
IGFBP-3 levels
(ng/ml)
Molar ratio of IGF-1 to IGFBP-3b
Control (19) 312.4 ± 14.5 53.5 ± 2.8 22.8 ± 1.6
Exercise (19) 283.0 ± 18.8 63.9 ± 3.4* 16.8 ± 1.6**
a Samples from Experiment 2. IGF-1 and IGFBP-3 levels were determined in serum samples by EIA. Values are mean ± SE of the number of samples 
(N) analyzed.
bMolar ratio was calculated by 3.7 × IGF-1 (ng/ml)/IGFBP-3 (ng/ml) due to 1 ng/mL IGF-I = 0.130 nM IGF-I and 1 ng/mL IGFBP3 = 0.036 nM IGFBP-
3.
*p < 0.03;**p < 0.005; two-tailed t-test.BMC Cancer 2008, 8:316 http://www.biomedcentral.com/1471-2407/8/316
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a 46% decrease in the nuclear levels of -catenin in the
tumors (p < 0.03). In normal small intestine, exercise did
not result in a significant change in those levels (Figure
1C).
Effect of voluntary exercise on PGE2 levels in small 
intestinal tumors and serum
In the ApcMin/+ mice maintained on AIN93G diet (Experi-
ment 1), the 6-week voluntary exercise resulted in signifi-
cantly decreased small intestinal tumor levels of PGE2 by
31% (Table 3; p < 0.05). In the ApcMin/+ mice maintained
on the high-fat diet (Experiment 2), the 9-week voluntary
exercise resulted in decreases in serum levels of PGE2 by
11% (p = 0.05), respectively. In the small intestinal
tumors, PGE2 levels were found to be decreased (by 23%)
in the exercise group compared to those levels in the con-
trol group.
Effects of voluntary exercise on colon tumorigenesis and 
body fat levels in AOM/DSS-treated mice on a high-fat diet 
(Experiment 3)
Male AOM/DSS-treated mice maintained on the high-fat
diet in cages equipped with a running wheel for 16 weeks
ran approximately 3.3 km/mouse/day. The 16-weeks of
voluntary exercise resulted in a significantly lower number
of colon tumors per tumor bearing mouse (49% of con-
trol, p < 0.05; Table 4). Voluntary exercise resulted in a
62% decrease in omental fat pad weight/body weight (p <
0.05) and a 60% decrease in retroperitoneal fat weight/
body weight (p < 0.05). The voluntary exercise increased
food and fluid intake (11% and 32%, respectively) but
decreased final body weights (by 14%). The mice housed
in cages equipped with a running wheel appeared to be
more aggressive than the control mice in the regular cage.
We observed that the mice in the exercise group often
fought each other; most of these mice had scratch marks
on their skin.
Discussion
The present study indicates that the opportunity to engage
in voluntary running wheel exercise decreases the number
of small intestinal tumors in female ApcMin/+ mice main-
tained on AIN93G or a high fat diet by ~30% (Table 1)
and the number of colon tumors (per tumor bearing
mice) in male AOM/DSS-treated mice maintained on a
high-fat diet by 51% (Table 4). Effects of voluntary or
forced exercise on colon tumor formation in AOM/DSS-
treated mice have not been reported, and the present
study is the first that shows the inhibitory effect of volun-
tary exercise on colon tumorigenesis in this model.
Voluntary exercise has been shown previously to inhibit
chemically-induced colon tumorigenesis in rats [6,7], but
this beneficial effect has not been shown previously in the
ApcMin/+ mouse model [9]. Forced exercise was shown to
inhibit tumorigenesis in male ApcMin/+ mice in one study
[9], but was without beneficial effect in a second study [8].
In addition, in previous studies, neither forced nor volun-
Table 4: Effect of voluntary exercise on body weights, regional fat weights, and colon tumor formation in AOM/DSS-treated mice on 
high-fat dieta
Groups (N) Final body 
weight per 
mouse (g)
Omental fat 
weight/final body 
weight per mouse 
(mg/g)
Retroperitoneal 
fat weight/body 
weight per mouse 
(mg/g)
Tumor 
incidence
No. of tumor 
per mouse
No. of tumor 
per tumor-
bearing/mouse
Average tumor 
dimensionb per 
tumor (mm)
Control (22) 49.9 ± 1.7 32.7 ± 3.6 10.6 ± 1.2 10/22 (46%) 1.9 ± 0.6 4.1 ± 1.0 2.7 ± 0.03
Exercise (17) 43.0 ± 1.2* 12.4 ± 2.6** 4.2 ± 1.0** 9/17 (53%) 1.1 ± 0.3 2.0 ± 0.2* 2.9 ± 0.07
aResults of Experiment 3. The mice were maintained on a high-fat diet and housed in regular cages or cages equipped with a running wheel for 16 
weeks. Values are mean ± SE of the number of samples (N) analyzed.
bAverage of length, width, and height of each tumor. There was no difference in the average volume of tumors (mm3) calculated using the formula V 
= 4/3r3 (r :the average dimention/2) between the two groups.
**p < 0.05 by two-tailed t-test. *p = 0.06 by two-tailed t-test and p = 0.03 by one-tailed t-test. Values with no superscript did not differ from the 
values of the control group statistically (p > 0.05)
Table 3: Effect of voluntary exercise on small intestinal tumor or 
serum levels of PGE2 in ApcMin/+ micea
Group (N) PGE2 levels (% decrease)
Experiment 1
Small intestinal tumors (ng/mg protein)
Control (11) 12.7 ± 1.4
Exercise (10) 8.8 ± 0.8b (31%)
Experiment 2
Serum (pg/ml)
Control (19) 436.4 ± 103.6
Exercise (19) 390.3 ± 111.7 (11%)
Small intestinal tumors (ng/mg protein)
Control (13) 26.5 ± 4.0
Exercise (13) 20.5 ± 2.4 (23%)
aSamples from Experiments 1 and 2. PGE2 levels were determined in 
small intestinal tumor extracts and(or) serum samples by EIA. Values 
are mean ± SE of the number of samples (N) analyzed.
bp  0.05, two-tailed t-test.BMC Cancer 2008, 8:316 http://www.biomedcentral.com/1471-2407/8/316
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Effects of voluntary exercise on protein levels of E-cadherin and nuclear -catenin in small intestinal tumors and normal small  intestine of ApcMin/+ mice on AIN93G diet Figure 1
Effects of voluntary exercise on protein levels of E-cadherin and nuclear -catenin in small intestinal tumors 
and normal small intestine of ApcMin/+ mice on AIN93G diet. Samples from Experiment 1. A. Western blot analyses of 
postnuclear (for E-cadherin) and nuclear (for -catenin) fraction of 6 representative tumor samples (out of a total of 9 samples 
analyzed) per group. Tumors used for these analyses were ~1 mm in the largest diameter. B. Protein levels were quantified by 
using Adobe Photoshop software (normalized by levels of -actin for E-cadherin and levels of histone H3 for nuclear -cat-
enin). Columns: mean values (in arbitrary units) of the number of mice (9 per group); bars: SE; *: p < 0.03 by two-tailed t-test. 
C. Western blot analyses of postnuclear (for E-cadherin) and nuclear (for -catenin) fraction of 4 representative normal small 
intestine samples per group.
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tary exercise were found to inhibit tumorigeneisis in
female ApcMin/+ mice [8,9]. The reasons for the inconsist-
ent results from the different studies in ApcMin/+mice are
not clear. One possible reason is the large variation in
tumor yield among individual ApcMin/+ mice (high varia-
bility across mice is often observed in our laboratory as
well as in other research groups), which by chance might
have resulted in false-negative results when small num-
bers of animals are used. Colbert et al. reported that vol-
untary exercise combined with food deprivation and
weight loss resulted in a reduction in tumor formation in
male ApcMin/+ mice [10]. The authors concluded that the
negative energy balance caused by the combination of
food deprivation and exercise was the underlying mecha-
nism for tumor reduction. In the present study, we found
that voluntary exercise significantly inhibited small intes-
tinal tumorigenesis in female ApcMin/+ mice on a normal
AIN93G or a high-fat diet as well as colon tumorigenesis
AOM/DSS-treated male mice on a high-fat diet. Since
mice in the present study were not food deprived, we con-
clude instead that exercise caused the inhibition of tumor-
igenesis under normal physiological conditions.
It was recently reported that voluntary running wheel
exercise decreased the thickness of the dermal fat layer and
inhibited ultraviolet B light-induced skin carcinogenesis
in SKH-1 mice [18]. Also, a highly significant correlation
between dermal fat thickness away from tumors and the
skin tumor multiplicity was found across individual mice
[18,19], suggesting that the exercise-induced reduction in
dermal fat contributed to the inhibition of skin tumori-
genesis. In order to assess the relationship between
regional body fat and the number of intestinal tumors in
individual mice in our study, we performed linear regres-
sion analysis. However, a statistically significant associa-
tion between the weight of regional body fat (omental or
retroperitoneal) and the number of intestinal tumors (in
different sizes and locations) per mouse was not found
(data not shown). In our study, ApcMin/+ mice maintained
on the high-fat diet had greater omental and retroperito-
neal body fat weight/body weight (by 21% and 87%) than
the ApcMin/+ mice on AIN93G diet, but intestinal tumor
numbers were not significantly different. Moreover, we
previously reported that administration of caffeine
decreased the two regional body fat weights, but did not
inhibit intestinal tumorigenesis in the ApcMin/+  mouse
model [16]. Taken together, these results suggest that the
reduction of body fat levels may not be responsible for the
inhibition of intestinal tumorigenesis caused by voluntary
exercise in the ApcMin/+ mouse model.
High circulating levels of IGF-1 and low levels of IGFBP-3
(a major IGFBP that accounts for ~75% of IGF-1 bound)
have been shown to be associated with an increased risk
of several types of cancers, including colorectal cancer
[20,21]. We found that voluntary exercise increased serum
IGFBP-3 levels and decreased IGF-1/IGFBP-3 ratio (Table
2). The decrease in serum IGF-1 levels was not statistically
significant (Table 2), and this is consistent with previous
studies in the ApcMin/+mouse model [8,9] as well as other
models [22,23]. In order to assess the relationship
between IGFBP-3, IGF-1, or IGF-1/IGFBP-3 ratio and
intestinal tumor numbers in individual mice, linear
regression analysis was performed with data from 38 mice
(in Experiment 2), but no significant associations were
found (data not shown). It is still of interest, however, to
further investigate how voluntary exercise increases
IGFBP-3 levels and how this effect could contribute to the
inhibitory action on intestinal tumorigenesis.
The observed increase of E-cadherin levels and decrease of
nuclear -catenin levels in tumors (Figure 1) may contrib-
ute to the inhibition of tumorigenesis in ApcMin/+ mice by
exercise because aberrant -catenin signaling is a key
molecular event in the development of intestinal tumors
in this model [24]. Similar events have been associated
with the cancer preventive activities of (-)-epigallocate-
chin-3-gallate (EGCG), the major polyphenolic com-
pound found in green tea [16]. The observed decrease in
levels of PGE2 in serum and tumors (Table 3) may also
contribute to the inhibition of intestinal tumorigenesis. It
has been well demonstrated that reduction of PGE2 pro-
duction decreases colorectal carcinogenesis [25]. A high
level of leisure-time physical activity has been reported to
be associated with low PGE2 levels in rectal mucosa [26].
In the present study, five mice were group-housed in each
cage; therefore, we could not determine how much each
mouse ran each day. We did observe that 2–4 mice could
run on the running wheel together. Nonetheless, it is pos-
sible that dominant mice gained more assess to the wheel
than subordinates. However, if this were the case, we
would predict high variability in the exercise group on
measures of tumor number, body weight, fat weight, etc.
In the present study, the variability observed in these
parameters in the exercise groups was similar to that
observed in the corresponding control groups. Therefore,
although there were five mice per cage, we conclude they
each contributed about equally to the number of wheel
revolutions.
Conclusion
We found that voluntary running wheel exercise inhibited
small intestinal tumor formation in female ApcMin/+ mice
and colon tumor formation in AOM/DSS-treated male
CF-1 mice, and the inhibitory effect may be associated
with decreased IGF-1/IGFBP-3 ratio as well as aberrant -
catenin signaling and arachidonic acid metabolism. Fur-
ther studies are needed to better characterize the mecha-
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